Retracted: p14ARF induces G2 cell cycle arrest in p53- and p21-deficient cells by down-regulating p34cdc2 kinase

Guillaume Normand1, Philipp G Hemmati, Berlinda Verdoodt

  • 1Department of Hematology, Oncology and Tumor Immunology, University Medical Center Charité, Campus Berlin-Buch, D-13125 Berlin-Buch, Germany.

Insights

The tumor suppressor p14-ARF induces a G2 cell cycle arrest in cancer cells lacking p53 or p21 by targeting the p34(cdc2) kinase. This mechanism prevents uncontrolled proliferation in cells with compromised tumor suppression pathways.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oncology

Background:

  • The INK4a gene locus encodes tumor suppressors p16(INK4a) and p14(ARF).
  • p14(ARF) is implicated in p53-independent cell cycle regulation.
  • p53 and p21 are key regulators of the cell cycle and tumor suppression.

Purpose of the Study:

  • To investigate the role of p14(ARF) in cell cycle regulation, particularly in cells with deficient p53/p21.
  • To elucidate the molecular mechanisms by which p14(ARF) induces cell cycle arrest.

Main Methods:

  • Cell cycle analysis using flow cytometry.
  • Western blotting to assess protein expression and phosphorylation.
  • Co-immunoprecipitation to investigate protein interactions.
  • Expression of constitutively active p34(cdc2AF) mutant.

Main Results:

  • p14(ARF) induces a G2 arrest in tumor cells lacking functional p53 and/or p21.
  • p14(ARF) expression leads to decreased p34(cdc2) kinase activity and protein levels.
  • p14(ARF) causes increased inhibitory Tyr-15 phosphorylation of p34(cdc2) and reduced cdc25C expression.
  • A phosphorylation-deficient p34(cdc2AF) mutant rescues the G2 arrest.

Conclusions:

  • p14(ARF) arrests cells in G2 by targeting p34(cdc2) kinase in a p53/p21-independent manner.
  • This G2 arrest mechanism acts as a fail-safe to prevent proliferation of tumor cells with compromised tumor suppressors.
  • p14(ARF) plays a critical role in maintaining genomic stability by halting cell division in cells with defective cell cycle checkpoints.

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...